Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05021198 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Norwegian Cerebral Venous Thrombosis Study

Study acronym: NoCVT
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Collaborators revised (15)v5 See this version in full on ClinicalTrials.gov ↗
  2. Primary completion date: Dec 31, 2024 to Dec 31, 2026 Start date: Jan 1, 2010 to Jan 1, 2014 · Completion date: Jan 2025 to Jan 2027 · Eligibility criteria revised · 1 morev4 Show 4 more changesShow less
    • Start date: Jan 1, 2010 to Jan 1, 2014
    • Completion date: Jan 2025 to Jan 2027
    • Eligibility criteria revised
    • Study description revised

    See this version in full on ClinicalTrials.gov ↗

  3. Eligibility criteria revised Study description expanded, about 14 words · Collaborators: 12 to 15v3 Show 2 more changesShow less
    • Study description expanded, about 14 words
    • Collaborators: 12 to 15

    See this version in full on ClinicalTrials.gov ↗

  4. Collaborators: 10 to 12v2 See this version in full on ClinicalTrials.gov ↗
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The NoCVT study will investigate CVT (2014-2023) in a large Norwegian population (\> 3 millions) using several approaches combining existing health registries, clinical databases and new prospectively collected clinical data to explore epidemiology, risk factors, diagnostics, treatment, and the long-term prognosis of CVT.
Trial Details
NCT Number NCT05021198
Lead Sponsor University Hospital, Akershus
Collaborators: Oslo University Hospital, Haukeland University Hospital, Drammen sykehus, Sorlandet Hospital HF, St. Olavs Hospital, Nordlandssykehuset HF, University Hospital of North Norway, University of Oslo, Rigshospitalet, Denmark, Hospital de Santa Maria, Portugal, Sykehuset Innlandet HF, Molde Hospital, Helse Stavanger HF, Sykehuset Telemark, Sykehuset i Vestfold HF
Conditions Cerebral Vein Thrombosis, Cerebral Venous Sinus Thrombosis
Enrollment 600 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov